Sophia Genetics SA (SOPH)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $703.25M
Last updated: Nov 17, 2026 at 4:15 PM ET
Sophia Genetics SA (SOPH) Stock Chart
Sophia Genetics SA (SOPH) has a latest price of $7.45 on Nov 17, 2026, 17.0% below its 52-week high of $8.98. Its price rose 72.9% over the past 12 months. The month-end price fell 46.2% over the 5 years through Oct 2026, a compound annual decline of 11.7%.
Price Chart
From Jul 2021 to Oct 2026, its highest month-end close was $19.77 in Aug 2021 and its lowest $2.06 in Dec 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart SOPH with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SOPH.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 10.0%, and over 6 months it rose 59.2%. The month-end price rose 106.8% over the 3 years through Oct 2026, a compound annual rate of 27.4%.
| Period | Change |
|---|---|
| 1 month | +14.8% |
| 3 months | -10.0% |
| 6 months | +59.2% |
| 12 months | +72.9% |
| 12 months, with dividends | +72.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +106.8% | +27.4% |
| 5 years | -46.2% | -11.7% |
Price by Year
Its best calendar year was 2023, when the price rose 128.6%, and its weakest was 2022, when it fell 85.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $7.63 | +63.4% |
| 2025 | $4.67 | +52.1% |
| 2024 | $3.07 | -34.8% |
| 2023 | $4.71 | +128.6% |
| 2022 | $2.06 | -85.4% |
Trading Range
The price is 2.2% below its 50-day average of $7.62 and 22.7% above its 200-day average of $6.07.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $7.45 | |
| 52-week high | $8.98 | -17.0% |
| 52-week low | $3.83 | +94.5% |
| 50-day average | $7.62 | -2.2% |
| 200-day average | $6.07 | +22.7% |
Price Risk
Over 3 years, its largest fall from a peak was 52.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.52 |
| Largest fall, 1 year | -27.2% |
| Largest fall, 3 years | -52.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About SOPH
What is SOPH's 1-year price change?
Sophia Genetics SA's price rose 72.9% over the past 12 months. With dividends included, the 12-month total return was 72.9%.
What is SOPH's 5-year price change?
Sophia Genetics SA's month-end price fell 46.2% over the 5 years through Oct 2026, a compound annual decline of 11.7%. These figures leave out dividends.
What is SOPH's 52-week high and low?
Sophia Genetics SA's 52-week high is $8.98 and its 52-week low is $3.83. Its latest price of $7.45 on Nov 17, 2026 is 17.0% below the high.
What is SOPH's beta?
Sophia Genetics SA's 1-year beta against the S&P 500 is 1.52, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 27.2%.
Is the SOPH chart free?
Yes. Advanced Charting for SOPH is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
SOPH pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts